Business Context and Reporting Period
This Form 8-K, filed on July 18, 2025, by DENTSPLY SIRONA Inc. (XRAY), reports on significant corporate governance changes and references preliminary financial results for the quarter ended June 30, 2025. The filing details the appointment of a new Chief Executive Officer and the departure of the incumbent CEO, alongside a reaffirmation of the company's 2025 financial outlook.
Key Financial Metrics
The filing references a press release (Exhibit 99.1) containing select preliminary financial results for the three months ended June 30, 2025. However, the text of this 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The company has reaffirmed its 2025 outlook, but specific guidance figures are not included in this document.
Material Changes
- Leadership Transition: Simon D. Campion, who served as President and CEO since September 2022, is departing the company effective July 31, 2025. He has also resigned from the Board of Directors, reducing the board size from eleven to ten members.
- New CEO Appointment: Daniel T. Scavilla has been appointed President and CEO, effective August 1, 2025. Mr. Scavilla previously served as CEO of Globus Medical, Inc.
- Committee Changes: Upon his appointment as CEO, Mr. Scavilla will no longer serve on the Board's Audit and Finance Committee.
Outlook, Risks, and Unusual Items
Outlook: The company has reaffirmed its 2025 financial outlook, though specific targets are not detailed in this filing.
Compensation and Severance Arrangements:
- New CEO Compensation: Mr. Scavilla's employment agreement includes a $1,030,000 annual base salary, a target annual bonus of 135% of base salary, and long-term equity incentives valued at $7,750,000 annually starting in fiscal year 2026. He will receive an initial equity grant valued at approximately $6,400,000 and signing bonuses totaling up to $1,750,000 (including a $150,000 relocation bonus and a pro-rated additional signing bonus).
- Outgoing CEO Severance: Mr. Campion's separation agreement provides for severance under his existing employment agreement and the Key Employee Severance Benefits Plan. Additional benefits include vesting credit under the Supplemental Executive Retirement Plan through the third anniversary of his start date, up to $50,000 for home sale losses, up to $30,000 for moving expenses, and up to $10,000 for legal fees.
Risks: The filing includes standard forward-looking statement disclaimers, noting that results are subject to risks and uncertainties described in the company's most recent Form 10-K.
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for specific preliminary financial results for the quarter ended June 30, 2025, which are not detailed in the 8-K text.
- Examine the full text of the Scavilla Employment Agreement (Exhibit 10.1) to understand specific performance metrics for equity vesting and clawback provisions for signing bonuses.
- Review the Campion Separation Agreement (Exhibit 10.2) to confirm the total estimated cost of the CEO transition and specific conditions for severance payout.
- Verify the company's updated 2025 financial guidance in the referenced press release to assess the impact of the leadership change on future projections.